Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
Antiandrogens act as selective androgen receptor modulators at the proteome level in prostate cancer cells. [electronic resource] by
- Brooke, Greg N
- Gamble, Simon C
- Hough, Michael A
- Begum, Shajna
- Dart, D Alwyn
- Odontiadis, Michael
- Powell, Sue M
- Fioretti, Flavia M
- Bryan, Rosie A
- Waxman, Jonathan
- Wait, Robin
- Bevan, Charlotte L
Producer: 20160203
In:
Molecular & cellular proteomics : MCP vol. 14
Availability: No items available.
|
|
16.
|
FUS/TLS is a novel mediator of androgen-dependent cell-cycle progression and prostate cancer growth. [electronic resource] by
- Brooke, Greg N
- Culley, Rachel L
- Dart, D Alwyn
- Mann, David J
- Gaughan, Luke
- McCracken, Stuart R
- Robson, Craig N
- Spencer-Dene, Bradley
- Gamble, Simon C
- Powell, Sue M
- Wait, Robin
- Waxman, Jonathan
- Walker, Marjorie M
- Bevan, Charlotte L
Producer: 20110502
In:
Cancer research vol. 71
Availability: No items available.
|